Could lead exposure worsen multiple sclerosis? new study investigates
NCT ID NCT07423312
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will examine whether lead exposure is linked to multiple sclerosis (MS). Researchers will measure blood lead levels, oxidative stress markers, and epigenetic changes in 140 people with MS and healthy controls. The goal is to better understand how environmental factors like lead might influence MS.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal whether lead exposure plays a role in MS progression, pointing toward new prevention or monitoring strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly benefit participants, and results may not lead to clear clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?